James Moon

Company: EVOQ Therapeutics; University of Michigan

Job title: Co-Founder & Chief Scientific Officer; Professor of Pharmaceutical Sciences

Seminars:

A Novel NanoDisc Platform for Systemic Targeting of Lymphoid Tissues and Induction of Antigen-Specific Immune Tolerance 12:30 pm

Exploring how subcutaneous administration of NanoDisc targets multiple lymphoid tissues and immune system organs NanoDisc carrying autoantigen induces antigen-specific Tregs and Tr1 cells NanoDisc therapy exerts robust efficacy in preclinical models of Multiple Sclerosis and Type 1 DiabetesRead more

day: Day Two